| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC2994 | L-658758 | Blocker of the activity of human neutrophil elastase (NE), human proteinase-3, human macrophage metalloelastase, mouse macrophage metalloelastase and Pseudomonas aeruginosa elastase |
|
| DCC2995 | L-663581 | Novel partial agonist of the benzodiazepine receptor |
|
| DCC2996 | L-680833 | Potent, orally active monocyclic beta-lactam inhibitor of human polymorphonuclear leukocyte elastase (PMNL-E) |
|
| DCC2997 | L-682679 | HIV protease inhibitor |
|
| DCC2998 | L-687306 | Novel partial agonist of muscarinic M1 receptors |
|
| DCC2999 | L-696229 | HIV-1 non-nucleoside reverse transcriptase inhibitor |
|
| DCC3000 | L-708906 | Inhibitor of Human Immunodeficiency Virus Type 1 (HIV-1) |
|
| DCC3001 | L-731988 | Inhibitor of Strand Transfer, Preventing Integration and Inhibiting HIV-1 Replication in Cells |
|
| DCC3002 | L-735821 | Inhibitor of the KCNQ1 channel |
|
| DCC3003 | L-739758 | Potent glycoprotein IIb/IIIa inhibitor |
|
| DCC3004 | L-744832 | Ras farnesyltransferase inhibitor, inhibiting in p70(s6k) phosphorylation in mammary tumors, inducing tumor regression in transgenic mice by mediating alterations in both cell cycle control and apoptosis |
|
| DCC3005 | L-749329 | Dual ET(A)/ET(B) endothelin receptor antagonist |
|
| DCC3006 | L-768673 | Class III antiarrhythmic agent, selectively blocking the slowly activating cardiac delayed rectifier potassium current Iks |
|
| DCC3007 | L-770644 | Potent and selective agonist of the human beta3 adrenergic receptor |
|
| DCC3008 | L-778123 Featured | L-778123 is a dual FPTase and GGPTase-I inhibitor, with IC50s of 2 nM and 98 nM respectively. |
|
| DCC3009 | L-841411 | Novel HIV-1 integrase strand transfer inhibitor (INSTI), stabilizing an integrase-single blunt-ended DNA complex |
|
| DCC3010 | L-858051 | Chemically-modified forskolin with greater stability and water solubility than the parent compound |
|
| DCC3011 | L-870812 | Novel inhibitor of HIV-1 and SIV integrase |
|
| DCC3012 | L-94901 | The first organ-selective thyromimetic, lowering plasma low density lipoprotein (LDL) cholesterol and raising plasma high density lipoprotein (HDL) cholesterol levels |
|
| DCC3013 | L-97-1 | Adenosine A1 receptor antagonist, reducing allergic responses to house dust mite in an allergic rabbit model of asthma, improving survival and protecting the kidney in a rat model of cecal ligation and puncture induced sepsis, also improving survival and |
|
| DCC3014 | Lamellarin D | Top1mt inhibitor, targeting mitochondrial DNA |
|
| DCC3015 | la-mem | Glutamate receptor antagonist and radical scavenging agent |
|
| DCC3016 | Lanopepden Mesylate | Novel Peptide Deformylase Inhibitor against Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus |
|
| DCC3017 | laquinimod Sodium | Novel Modulator of autoimmune demyelination |
|
| DCC3018 | Largazole | Potent inhibitor of histone deacetylase |
|
| DCC3019 | Las191859 | Novel, potent and selective CRTh2 antagonist |
|
| DCC3020 | Lasiojasmonate A | Natural fungal phytotoxin, activating the plant jasmonic acid pathway |
|
| DCC3021 | Laspartomycin C | Lipopeptide antibiotic with activity against a range of Gram-positive bacteria including drug-resistant pathogens |
|
| DCC3022 | Lassbio-1135 | Novel dual TRPV1 antagonist and TNF-alpha production inhibitor |
|
| DCC3023 | Lassbio-1359 | Novel adenosine receptor agonist, inducing relaxation of corpus cavernosum; Novel selective phosphodiesterase-4 (PDE4) inhibitor associated with anti-TNF-α properties |
|
